Kate Haviland, CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp (BPMC), sold 32,302 shares at $88.80 ($2.9M) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Seasonal sale ($2.9M) by CHIEF EXECUTIVE OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.80 | 16,151 | $1.4M | 50.0% |
| 2 | $88.80 | 16,151 | $1.4M | 50.0% |
| Total | $88.80 avg | 32,302 | $2.9M | 100% |
| Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |
| BPMC | SELL | 2023-03-08 | $597K | — | Filing → |